We caught up with Prof Joachim Ehrlich (Head of Cardiology and Electrophysiology, St Josefs-Hospital, Wiesbaden, Germany) on the recent studies in the use of pulmonary vein isolation in patients with atrial fibrillation and heart failure and the advantages of cryoballoon ablation compared with radiofrequency ablation. He also gave us an overview of their recent cohort study and its findings.
Questions:
- What have recent studies taught us about the utility of pulmonary vein isolation in patients with atrial fibrillation and heart failure? (0.18)
- What are the advantages of cryoballoon ablation compared with radiofrequency ablation in the treatment of atrial fibrillation? (2.15)
- Could you give us a brief overview of your cohort study and its findings? (3.12)
- What are the limitations of cryoballoon ablation in this patient population? (4.26)
- What will be the impact of your findings on clinical practice? (5.06)
Speaker’s disclosures: Professor Joachim Ehrlich has nothing to declare in relation to this video interview.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Joachim Ehrlich, September 2020.
